A seroprevalence study of COVID-19 in IBD patients
Not Applicable
Recruiting
- Conditions
- inflammatory bowel disease (IBD) patients in the broad sense
- Registration Number
- JPRN-UMIN000040838
- Lead Sponsor
- Hyogo College of Medicine, Center for Inflammatory Bowel Disease, Division of Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
Not provided
Exclusion Criteria
patients with active COVID-19
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method a positive rate of an anti-SARS-CoV-2 IgG antibody in serum of IBD patient
- Secondary Outcome Measures
Name Time Method